At Alosa Health, we believe that medical decisions should be based on unbiased, evidence-based information. Our mission is to improve patient outcomes by identifying and disseminating the best evidence available, and to support health care professionals in providing optimal care, free of any commercial influence. We accomplish this through ACADEMIC DETAILING - interactive educational outreach to clinicians in their own offices that delivers the best evidence on optimal patient care.
External link for Alosa Health
419 Boylston Street
6th Floor
Boston, Massachusetts 02116, US
We're excited to work with Aetna, a CVS Health Company on this important program to combat the #opioidcrisis! #healthcare #education #evidencebasedmedicine
A new Aetna initiative in cooperation with Alosa Health, is helping doctors understand the best ways to treat chronic pain. The goal? To reduce the number of new #opioid users and lower risks for patients currently on opioid therapy. https://aet.na/2ZwH8wD #HealthCare #OpioidCrisis #Addiction
We've enjoyed our time at this year's NAMCP Medical Directors Institute Spring Managed Care Forum! #healthcare #EvidenceBasedMedicine
@US_FDA approved the first prescription digital therapy app for major #depression, designed to be used adjunctively with medication as a 6-week program. https://bit.ly/4cLKcKQ
We're set up and ready for this year's Rx Summit. Come say hi at booth 212! #RxSummit2024 #ThisIsWhyWeMeet
We're looking forward to returning for another great conference! Come by the exhibit hall and see us at booth 212. #RxSummit2024
We're excited to welcome hundreds of professionals to #RxSummit2024 in Atlanta next week! Share this post if you'll be there. 🤝✨ #ThisIsWhyWeMeet #RxSummit
In 2019, only 7.1% of patients in primary care with #obesity used weight management treatments such as medications, nutrition counseling, or bariatric surgery. JAMA Network Open https://shorturl.at/movyJ
In patients with subclinical #AF, apixaban led to a lower risk of stroke or systemic embolism but more major bleeding compared to aspirin. NEJM Group http://bit.ly/3N5aFrM
The 2023-2024 influenza vaccine is estimated to reduce the risk of severe illness by 50% according to early data from the Southern Hemisphere. Centers for Disease Control and Prevention https://bit.ly/46gyxj3
Proud of our friend, Tom Snedden, Director of the PACE Program for Pennsylvania's Department of Aging, and his continued work advocating for + supporting older Americans. He recently spoke with President Biden after the announcement of prescription drug negotiations under the Inflation Reduction Act. #healthcare #evidencebasedmedicine
Uninsured patients and immigrants with #COPD are more likely to need but less likely to be able to access mental health services. https://rb.gy/q0eec